What is NDC 68382-919?

68382-919 is the product NDC for methylprednisolone, Methylprednisolone 32 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for methylprednisolone?

48 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

methylprednisolone NDC 68382-919 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-919Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0919Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68382-919-01	6838209190168382091901	100 TABLET in 1 BOTTLE (68382-919-01)Marketed from May 1, 2018
68382-919-05	6838209190568382091905	500 TABLET in 1 BOTTLE (68382-919-05)Marketed from May 1, 2018
68382-919-11	6838209191168382091911	25 TABLET in 1 BOTTLE (68382-919-11)Marketed from May 1, 2018
68382-919-77	6838209197768382091977	10 BLISTER PACK in 1 CARTON (68382-919-77) / 10 TABLET in 1 BLISTER PACK (68382-919-30)Marketed from May 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): methylprednisolone
Generic name (nonproprietary): methylprednisolone
Active ingredients: Methylprednisolone — 32 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 68382
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206751
Marketing start: May 1, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 68382-919_6cebff10-362f-41a7-8f66-3d9e878760fdSPL ID 6cebff10-362f-41a7-8f66-3d9e878760fdSPL set ID eaa9c932-c659-4ef6-bf5a-186545d87320RxCUI 197971, 197973, 259966, 328161, 762675UNII X4W7ZR7023
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382091901 followed by a unit qualifier and the quantity

Package 68382-0919-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1.Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2.Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require l…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68382-919

What is NDC 68382-919?: 68382-919 is the product NDC for methylprednisolone, Methylprednisolone 32 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: methylprednisolone.
What is the active ingredient?: Methylprednisolone.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for methylprednisolone?: 48 other product NDCs are listed under this name. See all methylprednisolone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other methylprednisolone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	BluePoint Laboratories	68001-624	68001-0624-01
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4213	70518-4213-00
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-961	60760-0961-21
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-3622	70518-3622-01
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0230	80425-0230-01
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0231	80425-0231-01
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0255	80425-0255-01
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Direct_Rx	72189-264	72189-0264-21
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-7833	68788-7833-02
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-2864	70518-2864-00

All 49 methylprednisolone NDCs

Other NDCs under ANDA 206751

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206751
Product	Strength	Form · route	Labeler	Product NDC
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Major Pharmaceuticals	0904-6914
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	A-S Medication Solutions	50090-3811
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	BluePoint Laboratories	68001-624
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-916
methylprednisolone	Methylprednisolone 8 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-917
methylprednisolone	Methylprednisolone 16 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-918
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-3622
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1348
methylprednisolone	Methylprednisolone 8 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1349
methylprednisolone	Methylprednisolone 16 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1350
methylprednisolone	Methylprednisolone 32 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1351
Methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0231
methylprednisolone	Methylprednisolone 4 mg/1	TabletOral	Proficient Rx LP	82804-007